Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 12/2002

01-12-2002

Symptomatic outcomes of laparoscopic antireflux surgery in patients eligible for endoluminal therapies

Authors: K.M. Desai, M.E. Klingensmith, E.R. Winslow, P. Frisella, N.J. Soper

Published in: Surgical Endoscopy | Issue 12/2002

Login to get access
Metadata
Title
Symptomatic outcomes of laparoscopic antireflux surgery in patients eligible for endoluminal therapies
Authors
K.M. Desai
M.E. Klingensmith
E.R. Winslow
P. Frisella
N.J. Soper
Publication date
01-12-2002
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 12/2002
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-002-8847-1

Other articles of this Issue 12/2002

Surgical Endoscopy 12/2002 Go to the issue

OriginalPaper

Laparoscopic gastric bypass in the treatment of morbid obesity

OriginalPaper

Computer-enhanced robotic telesurgery

OriginalPaper

Italian multicenter survey on laparoscopic treatment of gastro-esophageal reflux disease in children

OriginalPaper

In-line versus pistol-grip handles in a laparoscopic simulators

Erratum

Erratum

Legacy

News and notices